Clovis Oncology, Inc. CLVS
0.08 +0.08
Day range unavailable
52-week range unavailable
Discussion (3636)
Sign in to join the discussion
- This is ALL TRUE, BITCH:
Clovis Oncology’s Rubraca (Rucaparib) as First-Line Maintenance Treatment Significantly Improves Progression-Free Survival in Women with Advanced Ovarian Cancer in Primary Efficacy Analyses Regardless of BRCA Mutation and HRD Status
6/6/22, 8:00 AM
- I am adding HEAVY down here. On BO, Partnership, or ANY positive news, the fucker is going to SCREAM SQUEEZE
- Shorts will have the lower part of their colons jerked out by a BIG BULL COCK
- I can ALREADY see a MEGA SQUEEZE coming here
- Makes you wonder what kind of retarded thought process do you have to have to do a HARD PRESS SHORT PLAY on a company reporting POSITIVE CANCER DRUG NEWS?!!!
- The shorts here are NUTS! Absolutely NUTS! Total RETARDS
- Nothing like the POPPING sound of a shorts asshole getting RIPPED OPEN
- Looking forward to see the shorts get their asses GAPED
- The Tickeron guy sucks CUM from FAT WHITE BALLS
- These crooked MMs are starting to piss me the fuck off
